| Risk factors for intensive care unit-acquired weakness: A systematic review and meta-analysis |
16 |
| Early-SEPs' amplitude reduction is reliable for poor-outcome prediction after cardiac arrest? |
15 |
| Antiepileptic monotherapy in newly diagnosed focal epilepsy. A network meta-analysis |
15 |
| Sudden unexpected death in epilepsy: Risk factors, biomarkers, and prevention |
15 |
| Perceptions on the value of bodily functions in multiple sclerosis |
15 |
| Wearables in epilepsy and Parkinson's diseaseA focus group study |
12 |
| BRIVA-LIFE-A multicenter retrospective study of the long-term use of brivaracetam in clinical practice |
12 |
| Prehospital stroke scales and large vessel occlusion: A systematic review |
11 |
| Smoking and worsening disability in multiple sclerosis: A meta-analysis |
10 |
| Short-chain fatty acids and gut microbiota in multiple sclerosis |
10 |
| Perampanel, an AMPA receptor antagonist: From clinical research to practice in clinical settings |
10 |
| Rapidly increasing off-label use of rituximab in multiple sclerosis in Sweden Outlier or predecessor? |
10 |
| B cells in multiple sclerosis therapyA comprehensive review |
9 |
| Botulinum toxin: A review of the mode of action in migraine |
9 |
| Efficacy of ketogenic diet for infantile spasms: A systematic review |
9 |
| Evaluation of serum miR-191-5p, miR-24-3p, miR-128-3p, and miR-376c-3 in multiple sclerosis patients |
9 |
| Multiple sclerosis in Finland 2018-Data from the national register |
8 |
| Multiple sclerosis epidemiology in Finland: Regional differences and high incidence |
8 |
| Adjunctive perampanel in partial-onset seizures: Asia-Pacific, randomized phase III study |
8 |
| The effectiveness of greater occipital nerve blockade in treating acute migraine-related headaches in emergency departments |
7 |
| Quality of life in Parkinson's disease: A gender-specific perspective |
7 |
| Hippocampal subfield segmentation in temporal lobe epilepsy: Relation to outcomes |
7 |
| Adverse effects of anti-epileptics in trigeminal neuralgiform pain |
7 |
| Finding of increased caudate nucleus in patients with Alzheimer's disease |
7 |
| Transorbital ultrasonography for measuring optic nerve atrophy in multiple sclerosis |
7 |
| Optical coherence tomography in acute optic neuritis: A population-based study |
7 |
| Treatment of medication overuse headache-A review |
6 |
| Depression and risk of cognitive dysfunctions in amyotrophic lateral sclerosis |
6 |
| Structural and functional connectivity in newly diagnosed juvenile myoclonic epilepsy |
6 |
| Subthalamic deep brain stimulation and trunk posture in Parkinson's disease |
6 |
| Depression and anxiety in multiple system atrophy |
6 |
| Combination of flunarizine and transcutaneous supraorbital neurostimulation improves migraine prophylaxis |
6 |
| Retrospective study of perampanel efficacy and tolerability in myoclonic seizures |
6 |
| Progressive topological disorganization of brain network in focal epilepsy |
6 |
| Recurrent ischemic stroke: Incidence, predictors, and impact on mortality |
6 |
| Vitamin D supplementation and neurofilament light chain in multiple sclerosis |
5 |
| Challenges in epilepsy-The perspective of Norwegian epilepsy patients |
5 |
| Patient-reported outcomes in Friedreich's ataxia after withdrawal from idebenone |
5 |
| Comparison of plasma and cerebrospinal fluid neurofilament light in a multiple sclerosis trial |
5 |
| Incidence of osmotic demyelination syndrome in Sweden: A nationwide study |
5 |
| Restless legs syndrome and cerebrovascular/cardiovascular events: Systematic review and meta-analysis |
5 |
| Restless legs syndrome and its variants in acute ischemic stroke |
5 |
| Efficacy of CoQ10 as supplementation for migraine: A meta-analysis |
5 |
| Diffusion tensor imaging in multiple sclerosis at different final outcomes |
5 |
| Real-life clinical use of natalizumab and fingolimod in Austria |
5 |
| Effect of providing sudden unexpected death in epilepsy (SUDEP) information to persons with epilepsy (PWE) and their caregiversExperience from a tertiary care hospital |
5 |
| LRRK2 G2019S Parkinson's disease with more benign phenotype than idiopathic |
5 |
| Brain signal intensity changes as biomarkers in amyotrophic lateral sclerosis |
5 |
| Predictors to quality of life improvements after subthalamic stimulation in Parkinson's disease |
5 |
| Multimorbidity in patients with chronic migraine and medication overuse headache |
5 |
